Monitoring Cutaneous Leishmaniasis Lesions in Mice Undergoing Topical Miltefosine Treatment

Author:

Neira Laura Fernanda1,Mantilla Julio Cesar2,Escobar Patricia1ORCID

Affiliation:

1. Centro de Investigación en Enfermedades Tropicales (CINTROP-UIS), Departamento de Ciencias Básicas, Escuela de Medicina, Universidad Industrial de Santander, Bucaramanga 680002, Colombia

2. PAT-UIS, Departamento de Patología, Escuela de Medicina, Universidad Industrial de Santander, Bucaramanga 68002, Colombia

Abstract

A study was conducted on BALB/c mice infected with Leishmania (Leishmania) amazonensis to analyse the effects of 0.5% miltefosine (MTF) hydrogel treatment on cutaneous leishmaniasis (CL) lesions. The mice were treated for 25 days topically, and lesion sizes, parasite loads, histopathology, ultrastructure, cytokines including interleukin 4 (IL-4), tumour necrosis factor alfa (TNFα), interferon gamma (IFNγ), IL-10, and vascular endothelial growth factor (VEGF) profiles were evaluated on days 0, 12, 25, and 85. After 12 days of treatment, the lesion sizes and parasite numbers decreased. By day 60 post treatment, there were no lesions and only a few parasites. At day 25, there was a temporary papillomatosis reaction, an increase in mast cells, a few giant cells, and granulomas, and a decrease in diffuse inflammatory infiltrate and parasites. Transmission electron microscopy (TEM) examination showed early ultrastructural changes, including macrophages without parasites and vacuoles containing electrodense material. At the different evaluated times, the cytokine regulation indexes (ICRs) decreased for IL-4, TNFα, and VEGF. According to the study, the 0.5% MTF hydrogel was effective and showed positive results from the early stages of usage. The MTF directly targeted parasites, downregulated the release of IL-4, TNFα, and VEGF, increased mast cell production, and induced granuloma reaction during evaluation periods.

Funder

Colombian Ministry of Science, Technology, and Innovation, MINCIENCIAS-Colfuturo

MINCIENCIAS

Industrial University of Santander

Publisher

MDPI AG

Subject

Pharmaceutical Science

Reference51 articles.

1. (2023, October 08). Pan American Health Organization. Available online: https://www.paho.org/en/topics/leishmaniasis/cutaneous-and-mucosal-leishmaniasis.

2. Interventions for American cutaneous and mucocutaneous leishmaniasis;Pinart;Cochrane. Database Syst. Rev.,2020

3. Cutaneous leishmaniasis: Immune responses in protection and pathogenesis;Scott;Nat. Rev. Immunol.,2016

4. Persistence of leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: Is there a sterile cure?;Rodrigues;J. Infect. Dis.,2004

5. Costa-da-Silva, A.C., Nascimento, D.D., Ferreira, J.R.M., Guimarães-Pinto, K., Freire-de-Lima, L., Morrot, A., Decote-Ricardo, D., Filardy, A.A., and Freire-de-Lima, C.G. (2022). Immune responses in leishmaniasis: An overview. Trop. Med. Infect. Dis., 7.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Synthetic biology for combating leishmaniasis;Frontiers in Microbiology;2024-02-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3